Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 1.615B	--
--	2025/FY	-- / 1.378B	--
Mar 11, 2025	2024/FY	1.098B / 1.095B	--
Mar 24, 2022	2021/FY	76.325M / 51.900M	--
Mar 23, 2021	2020/FY	22.491M / 53.213M	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 1.615B--

--2025/FY-- / 1.378B--

Mar 11, 20252024/FY1.098B / 1.095B--

Mar 24, 20222021/FY76.325M / 51.900M--

Mar 23, 20212020/FY22.491M / 53.213M--

Unlock Free Earnings Estimates

Open Account

TOT BIOPHARM-B: Annual Report 2024

Apr 28 05:43 ET

TOT BIOPHARM-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024

Mar 11 10:47 ET

TOT BIOPHARM-B: DATE OF BOARD MEETING

Feb 27 03:56 ET

TOT BIOPHARM-B: INTERIM REPORT 2024

Sep 25, 2024 05:58 ET

01875 TOT BIOPHARM-B

TOT BIOPHARM-B Key Stats